Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,823 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00773344 | Clinical Trial of the Combination of Trastuzumab (Herceptin) and Tanespimycin in Patients With Solid Tumors and Her2 Positive Metastatic Breast Cancer That Have Previously Failed Herceptin | completed | Phase 1 / Phase 2 | 25 | Bristol-Myers SquibbINDUSTRY | 1 | Nov 4, 2015 | clinicaltrials |
| NCT00877474 | Phase I, Multicenter, Open-label, Dose-escalating, Clinical and Pharmacokinetic Study of PM01183 in Patients With Advanced Solid Tumors | completed | Phase 1 | 30 | PharmaMarINDUSTRY | 2 | Nov 4, 2015 |
| clinicaltrials |
| NCT01299636 | Study of PM060184 in Patients With Advanced Solid Tumors | completed | Phase 1 | 60 | PharmaMarINDUSTRY | 1 | Nov 2, 2015 | clinicaltrials |
| NCT01293630 | A Dose-escalation Study of Ombrabulin in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Tumors | completed | Phase 1 | 18 | SanofiINDUSTRY | 1 | Oct 30, 2015 | clinicaltrials |
| NCT00890435 | Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial | completed | — | 53 | Children's Oncology GroupNETWORK | 0 | Oct 21, 2015 | clinicaltrials |
| NCT01625156 | Tivantinib and Temsirolimus in Treating Patients With Solid Tumors That is Metastatic or Cannot be Removed by Surgery | completed | Phase 1 | 11 | National Cancer Institute (NCI)NIH | 1 | Oct 20, 2015 | clinicaltrials |
| NCT00557856 | A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors | completed | Phase 1 | 70 | PfizerINDUSTRY | 3 | Oct 19, 2015 | clinicaltrials |
| NCT01100931 | A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II) | completed | Phase 1 / Phase 2 | 42 | National Cancer Institute (NCI)NIH | 1 | Oct 19, 2015 | clinicaltrials |
| NCT01128998 | Sorafenib Plus S-1 in Advanced Solid Tumors | completed | Phase 1 | 30 | National Health Research Institutes, TaiwanOTHER | 1 | Oct 19, 2015 | clinicaltrials |
| NCT00003817 | Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy | completed | Phase 2 | 700 | Gary MorrowOTHER | 1 | Oct 15, 2015 | clinicaltrials |
| NCT00020657 | Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer | completed | Phase 3 | — | Gary MorrowOTHER | 1 | Oct 15, 2015 | clinicaltrials |
| NCT00042848 | Modafinil in Treating Fatigue in Patients Receiving Chemotherapy for Cancer | completed | Phase 3 | 837 | Gary MorrowOTHER | 1 | Oct 15, 2015 | clinicaltrials |
| NCT00276536 | Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma(IFNa) | completed | Phase 1 | 35 | The Cleveland ClinicOTHER | 1 | Oct 14, 2015 | clinicaltrials |
| NCT00255697 | Quality of Life of Older Patients Who Are Undergoing Treatment for Cancer and of Their Family Caregivers | completed | — | 863 | Case Comprehensive Cancer CenterOTHER | 1 | Oct 9, 2015 | clinicaltrials |
| NCT00884676 | Ixabepilone and Sunitinib Malate in Treating Patients With Progressive Advanced Solid Tumors | completed | Phase 1 | 36 | Jaime MerchanOTHER | 1 | Oct 9, 2015 | clinicaltrials |
| NCT00607724 | GDC-0449 in Treating Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 68 | Genentech, Inc.INDUSTRY | 0 | Oct 8, 2015 | clinicaltrials |
| NCT01039155 | Azacitidine and Oxaliplatin In Treating Patients With Advanced Cancers Relapsed or Refractory to Any Platinum Therapy | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Oct 6, 2015 | clinicaltrials |
| NCT01548482 | Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery | completed | Phase 1 | 21 | National Cancer Institute (NCI)NIH | 1 | Oct 6, 2015 | clinicaltrials |
| NCT00770536 | AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR | completed | Phase 1 | 103 | AmgenINDUSTRY | 3 | Sep 29, 2015 | clinicaltrials |
| NCT01317927 | A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies | completed | Phase 1 | 27 | Spectrum Pharmaceuticals, IncINDUSTRY | 1 | Sep 23, 2015 | clinicaltrials |
| NCT02525536 | A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of Trebananib (AMG 386 ) in Adult Japanese Participants With Advanced Solid Tumors | completed | Phase 1 | 18 | TakedaINDUSTRY | 0 | Sep 22, 2015 | clinicaltrials |
| NCT01560325 | Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers | completed | Phase 1 | 21 | Chong Kun Dang PharmaceuticalINDUSTRY | 1 | Sep 16, 2015 | clinicaltrials |
| NCT01071018 | A Study of MK2206 in Locally Advanced or Metastatic Solid Tumors (2206-007) | completed | Phase 1 | 24 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Sep 7, 2015 | clinicaltrials |
| NCT01383473 | Concurrent School Attendance And Cancer Therapy: The Experiences of 6-12 Year Old Pediatric Oncology Patients | completed | — | 14 | St. Jude Children's Research HospitalOTHER | 1 | Aug 27, 2015 | clinicaltrials |
| NCT01553656 | Dose-Finding Study of Cabozantinib (XL184) in Japanese Subjects With Advanced Cancer | completed | Phase 1 | 85 | ExelixisINDUSTRY | 1 | Aug 20, 2015 | clinicaltrials |
| NCT01362985 | Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor | completed | — | 201 | Genzyme, a Sanofi CompanyINDUSTRY | 0 | Aug 13, 2015 | clinicaltrials |
| NCT00022165 | Selenium in the Prevention of Cancer | completed | N/A | 501 | University of SurreyOTHER | 1 | Aug 11, 2015 | clinicaltrials |
| NCT01574235 | Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents | completed | — | 2,114 | Hospira, now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Jul 28, 2015 | clinicaltrials |
| NCT01627990 | Nivestim™ in Treatment of Malignant Diseases | completed | — | 386 | Hospira, now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Jul 24, 2015 | clinicaltrials |
| NCT00121277 | Vorinostat and Capecitabine in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 28 | University Health Network, TorontoOTHER | 1 | Jul 23, 2015 | clinicaltrials |
| NCT00126620 | Sorafenib and Erlotinib in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 17 | University Health Network, TorontoOTHER | 1 | Jul 23, 2015 | clinicaltrials |
| NCT01163903 | Pantoprazole With Doxorubicin for Advanced Cancer Patients With Extension Cohort of Patients With Solid Tumours | completed | Phase 1 | 24 | University Health Network, TorontoOTHER | 1 | Jul 15, 2015 | clinicaltrials |
| NCT01540175 | Immune Reconstitution in Oncology Patients Following Autologous Stem Cell Transplant(IROPAST) | completed | — | 31 | St. Jude Children's Research HospitalOTHER | 1 | Jul 14, 2015 | clinicaltrials |
| NCT02496949 | A Phase Ib Study to Assess Safety and Efficacy of Oral Icaritin in Advanced Solid Tumors | completed | Phase 1 | 28 | Chinese Academy of Medical SciencesOTHER | 1 | Jul 14, 2015 | clinicaltrials |
| NCT00413075 | Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | 121 | Valerio TherapeuticsINDUSTRY | 3 | Jul 8, 2015 | clinicaltrials |
| NCT00608361 | Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery | completed | Phase 1 | 80 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2015 | clinicaltrials |
| NCT01154426 | ABT-888 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 31 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2015 | clinicaltrials |
| NCT01725191 | Tivantinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors | completed | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 2 | Jul 2, 2015 | clinicaltrials |
| NCT01931761 | Study Evaluating Absorption, Distribution, Metabolism and Excretion (ADME) of Single Dose [14C] Selumetinib in Volunteers | completed | Phase 1 | 6 | AstraZenecaINDUSTRY | 1 | Jun 30, 2015 | clinicaltrials |
| NCT02063204 | To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Renal Impaired Subjects and Healthy Subjects | completed | Phase 1 | 24 | AstraZenecaINDUSTRY | 1 | Jun 30, 2015 | clinicaltrials |
| NCT02093728 | To Assess the Effect of Itraconazole and Fluconazole on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers | completed | Phase 1 | 26 | AstraZenecaINDUSTRY | 1 | Jun 30, 2015 | clinicaltrials |
| NCT00947739 | Phase I and Pharmacology Study of Camptothecin-20-O-Propionate Hydrate (CZ48) in Patients With Solid Tumors or Lymphoma | completed | Phase 1 | 43 | New Mexico Cancer Research AllianceOTHER | 1 | Jun 18, 2015 | clinicaltrials |
| NCT01544322 | Dose Escalation Study of the Safety and Pharmacokinetics of ME-344 Single Agent for Refractory Solid Tumors(ME-344-001) | completed | Phase 1 | 24 | MEI Pharma, Inc.INDUSTRY | 1 | Jun 18, 2015 | clinicaltrials |
| NCT01271972 | Study of Nesvacumab (REGN910/ SAR307746) | completed | Phase 1 | 53 | Regeneron PharmaceuticalsINDUSTRY | 2 | Jun 16, 2015 | clinicaltrials |
| NCT00096941 | A Study to Evaluate Subjects Treated With rhuMab 2C4 (Pertuzumab) in a Previous Genentech Phase II Cancer Study | completed | Phase 2 | 3 | Genentech, Inc.INDUSTRY | 0 | Jun 11, 2015 | clinicaltrials |
| NCT01017731 | Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes | completed | Phase 2 | 68 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 10, 2015 | clinicaltrials |
| NCT00005078 | Tirapazamine, Carboplatin, and Paclitaxel in Treating Patients With Advanced Malignant Solid Tumors | completed | Phase 1 | 44 | City of Hope Medical CenterOTHER | 1 | Jun 8, 2015 | clinicaltrials |
| NCT00005839 | Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid Tumor | completed | Phase 1 | — | City of Hope Medical CenterOTHER | 1 | Jun 8, 2015 | clinicaltrials |
| NCT00550901 | Dexrazoxane and Cisplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 25 | City of Hope Medical CenterOTHER | 0 | Jun 8, 2015 | clinicaltrials |
Data updated 24 days agoSource updated Nov 4, 2015source: clinicaltrials